VistaGen Therapeutics Announces USPTO Grant of Patent for Treatment of Depression with Fast-Acting PH10 Neuroactive Nasal Spray

Stock Information for VistaGen Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.